Skip to main content
. 2022 Mar 12;24(3):281–293. doi: 10.1177/10998004211069619

Table 1.

Comparisons of Psychoneurological Symptoms Pre-(T1) and Post-(T2) Chemotherapy Cycle.

Variable T1 (n = 40) T2 (n = 39) d p-value
Pain (mean [SD]) 41.8 (9.2) 41.5 (9.0) .80 a
Fatigue (mean [SD]) 44.9 (13.8) 43.7 (14.3) .53 a
Anxiety (mean [SD]) 43.9 (11.0) 42.4 (11.8) .26 a
Depressive symptoms (mean [SD]) 46.0 (12.0) 43.9 (10.5) .11 a
Pain group (T score ≥50 vs.<50), n (%) 6 (15) versus 34 (85) 8 (20.5) versus 31 (79.5) .63 b
Fatigue group (T score ≥50 vs.<50), n (%) 14 (35) versus 26 (65) 15 (38.5) versus 24 (61.5) .99 b
Anxiety group (T score ≥50 vs. <50), n (%) 11 (27.5) versus 29 (72.5) 8 (20.5) versus 31 (79.5) .45 b
Depressive symptoms group (T score ≥50 vs. <50), n (%) 13 (32.5) versus 27 (67.5) 12 (30.8) versus 27 (69.2) .99 b
PNS cluster across groups, n (%) <0.0001 c
0 23 (29.1) 18 (46.2)
1 2 (2.5) 9 (23.1)
2 8 (10.1) 5 (12.8)
3 4 (5.1) 4 (10.3)
4 3 (3.8) 3 (7.7)

Note. T1, pre-chemotherapy; T2, post-chemotherapy. PNS, psychoneurological symptoms; SD, standard deviation.

aPaired t-test.

bMcNemar test.

cChi-Square test.

d One patient with missing data of PNS post-chemotherapy, thus, our analyses were conducted for 39 patients.